NDC 51662-1415
Chromium Chromic Chloride 4 ug per 1 mL injection, solution
On the label: HF Acquisition Co. LLC. DBA HealthFirst. It's repackaged: HF Acquisition Co. LLC. DBA HealthFirst rebottles it from Hospira, Inc.'s NDC 0409-4093.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Hospira, Inc. | Rocky Mount, NC, United States | Makes it, tests it, packages it and labels it | No problems foundFeb 7, 2025 · 11 inspections, 3 with FDA action |
Repackaging site
- HF Acquisition Co LLC, Mukilteo, WA, United States · relabels it
Recalls
- Nov 1, 2016 · Class II · Hospira Inc.
Lack of Assurance of Sterility: Complaints of broken tips on the ampules.
Lots: Lot #5 9277EV, 60028EV, 6008EV, Exp 11/1/17
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Chromic Cation: every company that makes it
- Form
- injection, solution
- Strength
- 4 ug per 1 mL
- Approval
- NDA NDA018961
- On the market since
- Oct 18, 2019
- Package NDCs
51662-1415-1- Official label
- DailyMed (National Library of Medicine), updated Feb 22, 2020
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?